Testing for COVID-19 in lung cancer patients.
作者信息
Passaro A, Peters S, Mok T S K, Attili I, Mitsudomi T, de Marinis F
机构信息
Division of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland.
出版信息
Ann Oncol. 2020 Jul;31(7):832-834. doi: 10.1016/j.annonc.2020.04.002. Epub 2020 Apr 9.
Abstract
摘要
相似文献
1
Testing for COVID-19 in lung cancer patients.
Ann Oncol. 2020 Jul;31(7):832-834. doi: 10.1016/j.annonc.2020.04.002. Epub 2020 Apr 9.
2
SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
Pan Afr Med J. 2020 Apr 14;35(Suppl 2):4. doi: 10.11604/pamj.2020.35.4.22703. eCollection 2020.
3
Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic.
Mayo Clin Proc. 2020 Sep;95(9S):S17-S19. doi: 10.1016/j.mayocp.2020.05.039. Epub 2020 Jun 23.
4
[COVID-19 and Pulmonology: New Challenges and Opportunities].
Acta Med Port. 2020 Oct 1;33(10):710. doi: 10.20344/amp.14760. Epub 2020 Sep 2.
5
Editorial: Making the Best Use of Test Kits for COVID-19.
Am J Epidemiol. 2020 May 5;189(5):363-364. doi: 10.1093/aje/kwaa080.
6
Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01324-20.
7
Screening maternity populations during the COVID-19 pandemic.
BJOG. 2020 Nov;127(12):1557. doi: 10.1111/1471-0528.16439. Epub 2020 Sep 1.
8
COVID-19: An Unintended Force for Medical Revolution?
J Invasive Cardiol. 2020 Apr;32(4):E81-E82. doi: 10.25270/jic/20.3204.E81. Epub 2020 Mar 25.
9
Serological tests for COVID-19.
Med J Aust. 2020 Nov;213(9):397-399.e1. doi: 10.5694/mja2.50766. Epub 2020 Sep 6.
10
Laboratory diagnosis for Covid-19: A mini-review.
Rev Soc Bras Med Trop. 2020;53:e20200451. doi: 10.1590/0037-8682-0451-2020. Epub 2020 Aug 26.
引用本文的文献
1
Targeting Tumor Differentiation Grade-related Genes Prognostic Signature Including COL5A1 Based on Single-cell RNA-seq in Gastric Cancer.
Int J Med Sci. 2025 May 7;22(10):2533-2544. doi: 10.7150/ijms.107509. eCollection 2025.
2
Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12-2023.4 wave of the COVID-19 pandemic.
Front Immunol. 2024 Nov 6;15:1476186. doi: 10.3389/fimmu.2024.1476186. eCollection 2024.
3
Cuproptosis-associated lncRNA impact prognosis in patients with non-small cell lung cancer co-infected with COVID-19.
J Cell Mol Med. 2024 Sep;28(17):e70059. doi: 10.1111/jcmm.70059.
4
Coronavirus disease 2019 and lung cancer: where are we?
Explor Target Antitumor Ther. 2023;4(5):1082-1094. doi: 10.37349/etat.2023.00182. Epub 2023 Oct 30.
5
Add fuel to the fire: Inflammation and immune response in lung cancer combined with COVID-19.
Front Immunol. 2023 Mar 23;14:1174184. doi: 10.3389/fimmu.2023.1174184. eCollection 2023.
6
Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis.
Transl Oncol. 2023 Feb;28:101605. doi: 10.1016/j.tranon.2022.101605. Epub 2022 Dec 19.
7
Dying with Cancer and COVID-19, with Special Reference to Lung Cancer: Frailty as a Risk Factor.
Cancers (Basel). 2022 Dec 5;14(23):6002. doi: 10.3390/cancers14236002.
8
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.
Vaccines (Basel). 2022 Oct 20;10(10):1764. doi: 10.3390/vaccines10101764.
9
COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges.
J Int Med Res. 2022 Sep;50(9):3000605221125047. doi: 10.1177/03000605221125047.
10
Analysis of the Rate of Confirmed COVID-19 Cases in Seoul and Factors Affecting It Using Big Data Analysis.
Asia Pac J Public Health. 2022 Nov;34(8):824-831. doi: 10.1177/10105395221124435. Epub 2022 Sep 16.
本文引用的文献
1
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.
JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.
2
COVID-19 and smoking: A systematic review of the evidence.
Tob Induc Dis. 2020 Mar 20;18:20. doi: 10.18332/tid/119324. eCollection 2020.
3
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
4
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
5
Sex difference and smoking predisposition in patients with COVID-19.
Lancet Respir Med. 2020 Apr;8(4):e20. doi: 10.1016/S2213-2600(20)30117-X. Epub 2020 Mar 11.
6
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
7
Coronaviruses: Facts, Myths, and Hypotheses.
J Thorac Oncol. 2020 May;15(5):675-678. doi: 10.1016/j.jtho.2020.02.024. Epub 2020 Mar 7.
8
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
9
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
10
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.
Radiology. 2020 Aug;296(2):E32-E40. doi: 10.1148/radiol.2020200642. Epub 2020 Feb 26.
Zotero 插件